Get started
Author

Hamza BENBACHIR

Observed name: H Benbachir
OpenAlex ID: A5093243941
Study of iron deficiency in a population of blood donors in Tlemcen - Algeria
2023 · Hichem NAAS, Hamza BENBACHIR, et al. · GSC Biological and Pharmaceutical Sciences · 4
PDF
Real-life comparison of Nilotinib versus Dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients
2025 · Wiam HABERROU, Hamza BENBACHIR, et al. · GSC Biological and Pharmaceutical Sciences
PDF
Cost Effectiveness Analysis of Tyrosine Kinase Inhibitors in the Management of Chronic Myeloid Leukemia
2025 · Hamza BENBACHIR, Wiam HABERROU, et al. · GSC Biological and Pharmaceutical Sciences
PDF
Cytotoxic agents and pediatric particularity
2024 · Hichem NAAS, Hamza BENBACHIR, et al. · GSC Biological and Pharmaceutical Sciences
PDF
Therapeutic drug monitoring of imatinib in patients with chronic myeloid leukaemia: Experience from Oran HUE
2023 · Hamza BENBACHIR, Hichem NAAS, et al. · GSC Biological and Pharmaceutical Sciences
PDF
Pharmaco économie des stratégies thérapeutiques de la maladie de Crohn active Analyse coût-utilité de l'Infliximab vs adalimumab.
2019 · H Benbachir, S Guellil, et al.
Works count: 9
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type